Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
When treating primary liver disease with radiation, how do you contour and constrain the central bile ducts?
Related Questions
Would you offer inguinal nodal RT to a patient with anal SCC (pT1N1a, + inguinal node) following APR in the setting of prior prostate + pelvic nodal radiation?
When treating a high rectal cancer, does your coverage of the caudal mesorectum depend on the surgical plan?
What dose constraints and how much CTV do you extend into stomach for a patient with a GEJ tumor being treated with pre-operative or definitive chemo-RT?
For anal radiation dermatitis, does anyone have experience with 3M Cavilon protectant?
When treating inguinal lymph nodes in the setting of pelvic RT, what is your preferred setup in order to minimize dose to the penis?
How would you treat a patient with a synchronous T1N2 non-small cell lung cancer and a T3N1 mid-rectal adenocarcinoma (MMR intact)?
Do you always biopsy suspicious liver lesions if you have a biopsy from the pancreatic mass showing PDAC?
How do you approach repeat SBRT in the abdomen, specifically when considering constraints for bowel and mesenteric vessels?
For patients with large, partially or nearly obstructing rectal cancers, how do you sequence TNT in order to avoid complete obstruction and surgical diversion?
In patients with active IBD and rectal cancer, do you take any precautions before starting TNT?
